 <h1>Umeclidinium / vilanterol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to umeclidinium / vilanterol: inhalation powder</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, umeclidinium/vilanterol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking umeclidinium / vilanterol:</p><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chest pain</li>
<li>congestion</li>
<li>cough</li>
<li>dryness or soreness of the throat</li>
<li>fever</li>
<li>headache</li>
<li>hoarseness</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>stuffy or runny nose</li>
<li>tender, swollen glands in the neck</li>
<li>tightness of the chest</li>
<li>trouble breathing</li>
<li>trouble swallowing</li>
<li>voice changes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Chest discomfort</li>
<li>dizziness</li>
<li>fainting</li>
<li>fast or irregular heartbeat</li>
<li>itching, skin rash</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>sweating</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blindness</li>
<li>blurred vision</li>
<li>burning feeling while urinating</li>
<li>change in vision</li>
<li>decrease in frequency of urination</li>
<li>decreased vision</li>
<li>difficult or painful urination</li>
<li>difficulty in passing urine (dribbling)</li>
<li>eye pain</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>hives, itching, skin rash</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tearing</li>
<li>tremor</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of umeclidinium / vilanterol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>difficulty having a bowel movement</li>
<li>muscle spasms</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Belching</li>
<li>burning, dry, or itching eyes</li>
<li>discharge or excessive tearing</li>
<li>dry mouth</li>
<li>heartburn</li>
<li>indigestion</li>
<li>lack or loss of strength</li>
<li>redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Anxiety</li>
<li>change in or lack of taste</li>
</ul><p>
<!-- end inhalation powder --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to umeclidinium / vilanterol: inhalation powder</i></p><h3>General</h3><p>The most common adverse reaction was nasopharyngitis (9%).<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Diabetes Mellitus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, dry mouth, diarrhea, nausea, abdominal pain, toothache</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, gastroesophageal reflux disease, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Frequency not reported</b>: Signs and symptoms of urinary retention (e.g., difficulty passing urine, painful urination)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity, muscle spasms, neck pain, back pain, arthralgia</p>
<p><b>Uncommon</b> (0.1% to 1%): Musculoskeletal chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Postmarketing reports</b>: Dysgeusia, tremor<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, sinusitis, nasopharyngitis, lower respiratory tract infection, upper respiratory tract infections, cough, chest pain, pleuritic pain, viral respiratory tract infection, oropharyngeal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Productive cough, chest discomfort</p>
<p><b>Frequency not reported</b>: Paradoxical bronchospasm<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, rhythm idioventricular, tachycardia, supraventricular tachycardia</p>
<p><b>Frequency not reported</b>: Symptoms of increases in pulse rate, systolic or diastolic blood pressure</p>
<p><b>Postmarketing reports</b>: Palpitations<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Conjunctivitis</p>
<p><b>Frequency not reported</b>: Worsening of narrow-angle glaucoma (e.g., eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions, including anaphylaxis, angioedema, and urticaria</p><h3>Psychiatric</h3><p><b>Postmarketing reports</b>: Anxiety</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Anoro Ellipta (umeclidinium-vilanterol)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. Kelleher DL,  Mehta RS,  Jean-Francois BM, et al. "Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial." PLoS One 7 (2012): e50716</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Trelegy vs Anoro: Which is better?</li>
<li>How do you use an Anoro Ellipta inhaler?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about umeclidinium / vilanterol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>53 Reviews</li>
<li>Drug class: bronchodilator combinations</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Umeclidinium and vilanterol Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Anoro Ellipta</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>COPD</li>
<li>COPD, Maintenance</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to umeclidinium / vilanterol: inhalation powder</i></p><h3>General</h3><p>The most common adverse reaction was nasopharyngitis (9%).<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Diabetes Mellitus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, dry mouth, diarrhea, nausea, abdominal pain, toothache</p><p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, gastroesophageal reflux disease, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Frequency not reported</b>: Signs and symptoms of urinary retention (e.g., difficulty passing urine, painful urination)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity, muscle spasms, neck pain, back pain, arthralgia</p><p><b>Uncommon</b> (0.1% to 1%): Musculoskeletal chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Postmarketing reports</b>: Dysgeusia, tremor<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, sinusitis, nasopharyngitis, lower respiratory tract infection, upper respiratory tract infections, cough, chest pain, pleuritic pain, viral respiratory tract infection, oropharyngeal pain</p><p><b>Uncommon</b> (0.1% to 1%): Productive cough, chest discomfort</p><p><b>Frequency not reported</b>: Paradoxical bronchospasm<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, rhythm idioventricular, tachycardia, supraventricular tachycardia</p><p><b>Frequency not reported</b>: Symptoms of increases in pulse rate, systolic or diastolic blood pressure</p><p><b>Postmarketing reports</b>: Palpitations<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Conjunctivitis</p><p><b>Frequency not reported</b>: Worsening of narrow-angle glaucoma (e.g., eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions, including anaphylaxis, angioedema, and urticaria</p><h3>Psychiatric</h3><p><b>Postmarketing reports</b>: Anxiety</p><p id="ref_1">1. "Product Information. Anoro Ellipta (umeclidinium-vilanterol)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. Kelleher DL,  Mehta RS,  Jean-Francois BM, et al. "Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial." PLoS One 7 (2012): e50716</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Trelegy vs Anoro: Which is better?</li>
<li>How do you use an Anoro Ellipta inhaler?</li>
</ul><h2>More about umeclidinium / vilanterol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>53 Reviews</li>
<li>Drug class: bronchodilator combinations</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Umeclidinium and vilanterol Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>COPD</li>
<li>COPD, Maintenance</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>